Dr. Hönle AG Capital Reinvestment Ratio

Latest as of June 2026: 0.12x

Dr. Hönle AG capital reinvestment ratio. Dr. Hönle AG (HNL) has a Capital Reinvestment Ratio of 0.12x as of June 2026, meaning it reinvests 0% of its operating cash flow (€2.20 Million) in capital expenditures (€266.00K). Check HNL cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

€2.20 Million
EUR

Capital Expenditures

€266.00K
EUR

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Dr. Hönle AG (2014–2025)

Capital reinvestment ratio of Dr. Hönle AG from 2014 to 2025. This chart tracks Dr. Hönle AG's Capital Reinvestment Ratio across 11 annual periods. Also explore HNL net assets growth trend to track the company's year-over-year net asset growth rate.

Dr. Hönle AG Capital Reinvestment Ratio by Year (2014–2025)

Dr. Hönle AG capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Dr. Hönle AG (HNL) cash flow conversion.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.38x €4.99 Million €1.90 Million ▲ +0.5%
2024 0.38x €5.53 Million €2.09 Million ▼ -59.4%
2023 0.93x €3.14 Million €2.93 Million ▼ -93.8%
2021 15.12x €1.13 Million €17.09 Million ▲ +262.3%
2020 4.17x €7.23 Million €30.20 Million ▲ +266.5%
2019 1.14x €16.92 Million €19.28 Million ▲ +160.8%
2018 0.44x €24.22 Million €10.58 Million ▼ -46.4%
2017 0.81x €6.58 Million €5.36 Million ▲ +41.3%
2016 0.58x €8.63 Million €4.98 Million ▲ +147.3%
2015 0.23x €9.16 Million €2.14 Million ▼ -43.4%
2014 0.41x €7.49 Million €3.08 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow